Beyond Air Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Beyond Air's earnings have been declining at an average annual rate of -31.7%, while the Medical Equipment industry saw earnings growing at 12.9% annually. Revenues have been declining at an average rate of 68.8% per year.
Belangrijke informatie
-31.7%
Groei van de winst
-7.4%
Groei van de winst per aandeel
| Medical Equipment Groei van de industrie | 8.9% |
| Inkomstengroei | -68.8% |
| Rendement op eigen vermogen | -351.9% |
| Nettomarge | -3,272.5% |
| Volgende winstupdate | 11 Nov 2024 |
Recente prestatie-updates uit het verleden
Recent updates
We're Keeping An Eye On Beyond Air's (NASDAQ:XAIR) Cash Burn Rate
Apr 05
Will Beyond Air (NASDAQ:XAIR) Spend Its Cash Wisely?
Dec 14Beyond Air presents pilot at-home study data; stock earlier snaps 7-day losing streak
Oct 17Beyond Air: Bottom Line Fundamentals Keep Buyers At Bay
Sep 08Beyond Air affiliate Beyond Cancer doses patient in phase 1 study of ultra-high concentration nitric oxide therapy
Aug 23Beyond Air reaches six-month high after $2.3M insider transactions
Jul 06Companies Like Beyond Air (NASDAQ:XAIR) Are In A Position To Invest In Growth
May 02Opbrengsten en kosten
Hoe Beyond Air geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 2 | -58 | 34 | 25 |
| 31 Mar 24 | 1 | -60 | 38 | 24 |
| 31 Dec 23 | 1 | -67 | 41 | 22 |
| 30 Sep 23 | 0 | -63 | 40 | 20 |
| 30 Jun 23 | 0 | -59 | 38 | 18 |
| 31 Mar 23 | 0 | -56 | 35 | 17 |
| 31 Dec 22 | 0 | -56 | 32 | 16 |
| 30 Sep 22 | 0 | -51 | 28 | 13 |
| 30 Jun 22 | 0 | -47 | 23 | 12 |
| 31 Mar 22 | 0 | -43 | 19 | 11 |
| 31 Dec 21 | 0 | -28 | 16 | 10 |
| 30 Sep 21 | 0 | -26 | 13 | 11 |
| 30 Jun 21 | 1 | -23 | 12 | 11 |
| 31 Mar 21 | 1 | -23 | 10 | 13 |
| 31 Dec 20 | 1 | -23 | 9 | 14 |
| 30 Sep 20 | 1 | -22 | 9 | 13 |
| 30 Jun 20 | 1 | -21 | 9 | 13 |
| 31 Mar 20 | 1 | -20 | 9 | 11 |
| 31 Dec 19 | 9 | -15 | 9 | 9 |
| 30 Sep 19 | 9 | -13 | 9 | 7 |
| 30 Jun 19 | 8 | -11 | 8 | 5 |
| 31 Mar 19 | 8 | -7 | 7 | 4 |
| 31 Dec 18 | 0 | -5 | 5 | 4 |
| 30 Sep 18 | 0 | -5 | 4 | 5 |
| 30 Jun 18 | 0 | -10 | 4 | 5 |
| 31 Mar 18 | 0 | -11 | 5 | 5 |
| 31 Dec 17 | 0 | -18 | 7 | 4 |
| 30 Sep 17 | 0 | -17 | 6 | 3 |
| 30 Jun 17 | 0 | -11 | 5 | 2 |
| 31 Mar 17 | 0 | -9 | 3 | 2 |
| 31 Dec 16 | 0 | -4 | 1 | 1 |
| 30 Sep 16 | 0 | -3 | 1 | 1 |
| 30 Jun 16 | 0 | -4 | 1 | 1 |
| 31 Mar 16 | 0 | -4 | 1 | 1 |
| 31 Dec 15 | 0 | -4 | 1 | 2 |
| 30 Sep 15 | 0 | -4 | 1 | 2 |
| 30 Jun 15 | 0 | -4 | 1 | 2 |
| 31 Mar 15 | 0 | -4 | 1 | 1 |
| 31 Dec 14 | 0 | -5 | 1 | 1 |
Kwaliteitswinsten: XAIR is currently unprofitable.
Groeiende winstmarge: XAIR is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: XAIR is unprofitable, and losses have increased over the past 5 years at a rate of 31.7% per year.
Versnelling van de groei: Unable to compare XAIR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: XAIR is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (11.7%).
Rendement op eigen vermogen
Hoge ROE: XAIR has a negative Return on Equity (-351.95%), as it is currently unprofitable.